{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T04:13:35Z","timestamp":1779164015408,"version":"3.51.4"},"reference-count":19,"publisher":"BMJ","issue":"8","license":[{"start":{"date-parts":[[2025,8,24]],"date-time":"2025-08-24T00:00:00Z","timestamp":1755993600000},"content-version":"unspecified","delay-in-days":23,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"National Institutes of Health\/National Institute of Allergy and Infectious Diseases","award":["R01AI112970"],"award-info":[{"award-number":["R01AI112970"]}]},{"name":"National Institutes of Health\/National Institute of Allergy and Infectious Diseases","award":["R01AI137093"],"award-info":[{"award-number":["R01AI137093"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Glob Health"],"accepted":{"date-parts":[[2025,7,27]]},"published-print":{"date-parts":[[2025,8]]},"abstract":"<jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>Non-disease-specific WHO-CHOICE (CHOosing Interventions that are Cost-Effective) unit costs are often used in cost and cost-effectiveness studies in the absence of country-specific data. This study aims to compare reported country-specific disease costs and the corresponding WHO-CHOICE estimates, using generically defined \u2018diarrhoea\u2019 (including rotavirus diarrhoea) and pathogen-specific \u2018respiratory syncytial virus (RSV)\u2019 disease in children as examples.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We updated systematic reviews for both diseases in low-income (LICs), lower middle-income (LMICs) and upper middle-income (UMICs) countries. Diarrhoeal (including a subanalysis of rotavirus-specific diarrhoea) and RSV-specific outpatient and inpatient costs per episode in children were extracted and compared with WHO-CHOICE estimates in the same countries. All costs were updated to 2022 international dollar values. If a consistent pattern of underestimation or overestimation was identified, we quantified the magnitude of the discrepancy as the ratio of published disease-specific costs and corresponding WHO-CHOICE-based estimates.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Out of 1979 records identified, 23 cost studies were included. Including previous reviews, we retained 31 diarrhoea and 16 RSV studies for comparison. WHO-CHOICE-based direct medical costs were similar for diarrhoeal disease (including rotavirus diarrhoea), but lower for RSV-related disease. We estimated the cost per episode of diarrhoea and RSV in 128 countries. RSV outpatient costs were adjusted by multiplying WHO-CHOICE costs by 6.89 (95% uncertainty interval: 5.58 to 8.58) in LICs and LMICs and 5.87 (4.95 to 6.96) in UMICs; RSV inpatient costs were multiplied by 1.43 (1.01 to 2.01) and 1.36 (0.82 to 2.27), respectively.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>While informative for economic evaluations, WHO-CHOICE-based cost estimates should be used cautiously. Our analysis shows they aligned well with empirical studies for diarrhoeal disease but underestimated the costs of RSV-related disease. For diseases with few country-specific costing studies, comparing findings of the empirical studies with WHO-CHOICE estimates is crucial before conducting economic evaluations for countries without data. We propose a simple approach for calculating adjustment factors for WHO-CHOICE estimates when empirical data on disease-specific diagnosis and treatment costs are limited.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/bmjgh-2024-016784","type":"journal-article","created":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T01:35:23Z","timestamp":1756085723000},"page":"e016784","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["How well do disease-specific studies and WHO-CHOICE cost estimates align? Example of estimating cost per episode of diarrhoea and respiratory syncytial virus in 128 low-income and middle-income countries"],"prefix":"10.1136","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1918-1791","authenticated-orcid":false,"given":"Xiao","family":"Li","sequence":"first","affiliation":[{"name":"Public Health Modeling Unit, Yale School of Public Health, Yale University, New Haven, Connecticut, USA"},{"name":"Department of Epidemiology of Microbial Diseases, Yale School of Public Health, Yale University, New Haven, Connecticut, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joke","family":"Bilcke","sequence":"additional","affiliation":[{"name":"Public Health Modeling Unit, Yale School of Public Health, Yale University, New Haven, Connecticut, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4078-8755","authenticated-orcid":false,"given":"Ernest O","family":"Asare","sequence":"additional","affiliation":[{"name":"Department of Epidemiology of Microbial Diseases, Yale School of Public Health, Yale University, New Haven, Connecticut, USA"},{"name":"Centre for Health Economics Research and Modelling Infectious Diseases (CHERMID), University of Antwerp, Antwerp, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"Wenger","sequence":"additional","affiliation":[{"name":"Centre for Health Economics Research and Modelling Infectious Diseases (CHERMID), University of Antwerp, Antwerp, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2707-3547","authenticated-orcid":false,"given":"Jiye","family":"Kwon","sequence":"additional","affiliation":[{"name":"Department of Epidemiology of Microbial Diseases, Yale School of Public Health, Yale University, New Haven, Connecticut, USA"},{"name":"Centre for Health Economics Research and Modelling Infectious Diseases (CHERMID), University of Antwerp, Antwerp, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Louis","family":"Bont","sequence":"additional","affiliation":[{"name":"Centre for Health Economics Research and Modelling Infectious Diseases (CHERMID), University of Antwerp, Antwerp, Belgium"},{"name":"Department of Pediatric Infectious Diseases and Immunology, Wilhelmina Children\u2019s Hospital University Medical Centre, Utrecht, Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe","family":"Beutels","sequence":"additional","affiliation":[{"name":"Public Health Modeling Unit, Yale School of Public Health, Yale University, New Haven, Connecticut, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1015-2289","authenticated-orcid":false,"given":"Virginia E","family":"Pitzer","sequence":"additional","affiliation":[{"name":"Department of Epidemiology of Microbial Diseases, Yale School of Public Health, Yale University, New Haven, Connecticut, USA"},{"name":"Centre for Health Economics Research and Modelling Infectious Diseases (CHERMID), University of Antwerp, Antwerp, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2025,8,24]]},"reference":[{"key":"2025082418351856000_10.8.e016784.1","unstructured":"Unicef . Under-five mortality, 2023. Available: https:\/\/data.unicef.org\/topic\/child-survival\/under-five-mortality\/#:~:text=Globally%2C%20infectious%20diseases%2C%20including%20pneumonia,birth%20and%20intrapartum%2Drelated%20complications [Accessed 12 Feb 2024]."},{"key":"2025082418351856000_10.8.e016784.2","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-062360","article-title":"Novel care pathway to optimise antimicrobial prescribing for uncomplicated community-acquired pneumonia: study protocol for a prospective before-after cohort study in the emergency department of a tertiary care Canadian children\u2019s hospital","volume":"12","author":"Pernica","year":"2022","journal-title":"BMJ Open"},{"key":"2025082418351856000_10.8.e016784.3","unstructured":"PATH . RSV Vaccine and mAB Snapshot 2024, 2024. Available: https:\/\/www.path.org\/our-impact\/resources\/rsv-vaccine-and-mab-snapshot\/ [Accessed 13 Feb 2024]."},{"key":"2025082418351856000_10.8.e016784.4","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1016\/j.vaccine.2009.06.035","article-title":"WHO Guide for standardisation of economic evaluations of immunization programmes","volume":"28","author":"Walker","year":"2010","journal-title":"Vaccine (Auckl)"},{"key":"2025082418351856000_10.8.e016784.5","doi-asserted-by":"publisher","DOI":"10.1093\/jpids\/piaa157"},{"key":"2025082418351856000_10.8.e016784.6","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2019.1671134"},{"key":"2025082418351856000_10.8.e016784.7","doi-asserted-by":"crossref","DOI":"10.1186\/s12916-023-02792-z","article-title":"Cost of childhood RSV management and cost-effectiveness of RSV interventions: a systematic review from a low- and middle-income country perspective","volume":"21","author":"Wittenauer","year":"2023","journal-title":"BMC Med"},{"key":"2025082418351856000_10.8.e016784.8","doi-asserted-by":"crossref","DOI":"10.1186\/s12962-018-0095-x","article-title":"Econometric estimation of WHO-CHOICE country-specific costs for inpatient and outpatient health service delivery","volume":"16","author":"Stenberg","year":"2018","journal-title":"Cost Eff Resour Alloc"},{"key":"2025082418351856000_10.8.e016784.9","doi-asserted-by":"crossref","DOI":"10.7189\/jogh.07.010409","article-title":"Cost-effectiveness analysis of revised WHO guidelines for management of childhood pneumonia in 74 Countdown countries","volume":"7","author":"Zhang","year":"2017","journal-title":"J Glob Health"},{"key":"2025082418351856000_10.8.e016784.10","unstructured":"World health organization . Who Guide for Standardization of Economic Evaluations of Immunization Programmes. Geneva, Switzerland: World Health Organization, 2019."},{"key":"2025082418351856000_10.8.e016784.11","doi-asserted-by":"crossref","DOI":"10.1186\/s12889-020-08595-8","article-title":"Cost of illness for childhood diarrhea in low- and middle-income countries: a systematic review of evidence and modelled estimates","volume":"20","author":"Baral","year":"2020","journal-title":"BMC Public Health"},{"key":"2025082418351856000_10.8.e016784.12","doi-asserted-by":"publisher","DOI":"10.1177\/0962280219889080"},{"key":"2025082418351856000_10.8.e016784.13","unstructured":"The World Bank . Consumer Price Index (2010=100), 2023. Available: https:\/\/data.worldbank.org\/indicator\/FP.CPI.TOTL [Accessed 25 Sep 2023]."},{"key":"2025082418351856000_10.8.e016784.14","unstructured":"The World Bank . PPP conversion factor, GDP (LCU per international $), 2023. Available: https:\/\/data.worldbank.org\/indicator\/PA.NUS.PPP [Accessed 25 Sep 2023]."},{"key":"2025082418351856000_10.8.e016784.15","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1001\/jamapediatrics.2018.1960","article-title":"Rotavirus Vaccination and the Global Burden of Rotavirus Diarrhea Among Children Younger Than 5 Years","volume":"172","author":"Troeger","year":"2018","journal-title":"JAMA Pediatr"},{"key":"2025082418351856000_10.8.e016784.16","doi-asserted-by":"crossref","DOI":"10.1186\/s12879-023-08024-2","article-title":"Estimating the economic burden of respiratory syncytial virus infections in infants in Vietnam: a cohort study","volume":"23","author":"Do","year":"2023","journal-title":"BMC Infect Dis"},{"key":"2025082418351856000_10.8.e016784.17","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofz150","article-title":"Household Costs of Diarrhea by Etiology in 7 Countries, The Global Enterics Mulitcenter Study (GEMS)","volume":"6","author":"Zimmermann","year":"2019","journal-title":"Open Forum Infect Dis"},{"key":"2025082418351856000_10.8.e016784.18","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2016-000166","article-title":"Household expenditures on pneumonia and diarrhoea treatment in Ethiopia: a facility-based study","volume":"2","author":"Memirie","year":"2017","journal-title":"BMJ Glob Health"},{"key":"2025082418351856000_10.8.e016784.19","unstructured":"Shepard DS , Hodgkin D , Anthony YE . Analysis of Hospital Costs: A Manual for Managers. Geneva, Switerland: World Health Organization, 2000."}],"container-title":["BMJ Global Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjgh-2024-016784","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T01:35:27Z","timestamp":1756085727000},"score":1,"resource":{"primary":{"URL":"https:\/\/gh.bmj.com\/lookup\/doi\/10.1136\/bmjgh-2024-016784"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":19,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2025,8,24]]},"published-print":{"date-parts":[[2025,8]]}},"alternative-id":["10.1136\/bmjgh-2024-016784"],"URL":"https:\/\/doi.org\/10.1136\/bmjgh-2024-016784","relation":{},"ISSN":["2059-7908"],"issn-type":[{"value":"2059-7908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8]]}}}